Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4668)
All Articles published online
|
Apr 21, 2010 (publication date) through Apr 1, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hu WM, Li L, Jing BQ, Zhao YS, Wang CL, Feng L, Xie YE. Effect of S1P5 on proliferation and migration of human esophageal cancer cells. World J Gastroenterol 2010; 16(15): 1859-1866 [PMID: 20397263 DOI: 10.3748/wjg.v16.i15.1859] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i15/1859.htm |
| Number | Citing Articles |
| 1 |
Mohamad Adada, Daniel Canals, Yusuf A. Hannun, Lina M. Obeid. Sphingosine-1-phosphate receptor 2. FEBS Journal 2013; 280(24): 6354 doi: 10.1111/febs.12446
|
| 2 |
Katrin G. Schmidt, Martina Herrero San Juan, Sandra Trautmann, Lucija Berninger, Anja Schwiebs, Florian M. Ottenlinger, Dominique Thomas, Frank Zaucke, Josef M. Pfeilschifter, Heinfried H. Radeke. Sphingosine-1-Phosphate Receptor 5 Modulates Early-Stage Processes during Fibrogenesis in a Mouse Model of Systemic Sclerosis: A Pilot Study. Frontiers in Immunology 2017; 8 doi: 10.3389/fimmu.2017.01242
|
| 3 |
Surinder M. Soond, Andrey A. Zamyatnin. GPCR Signaling in Cancer. Advances in Cancer Research 2020; 145: 49 doi: 10.1016/bs.acr.2019.11.002
|
| 4 |
Franck Talmont, Elodie Mitri, Christine Dozier, Arnaud Besson, Olivier Cuvillier, Anastassia Hatzoglou. Sphingosine 1-Phosphate Receptor 5 (S1P5) Deficiency Promotes Proliferation and Immortalization of Mouse Embryonic Fibroblasts. Cancers 2022; 14(7): 1661 doi: 10.3390/cancers14071661
|
| 5 |
Mohamad Bahij Moumneh, Tarek Bou Dargham, Marguerite Mrad, Ghassan Dbaibo. Handbook of Cancer and Immunology. 2023; : 1 doi: 10.1007/978-3-030-80962-1_264-1
|
| 6 |
Christin Wünsche, Alexander Koch, Roel Goldschmeding, Stephanie Schwalm, Dagmar Meyer zu Heringdorf, Andrea Huwiler, Josef Pfeilschifter. Transforming growth factor β2 (TGF-β2)-induced connective tissue growth factor (CTGF) expression requires sphingosine 1-phosphate receptor 5 (S1P5) in human mesangial cells. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 2015; 1851(5): 519 doi: 10.1016/j.bbalip.2015.01.003
|
| 7 |
Preeti Gupta, Aaliya Taiyab, Afzal Hussain, Mohamed F. Alajmi, Asimul Islam, Md. Imtaiyaz Hassan. Targeting the Sphingosine Kinase/Sphingosine-1-Phosphate Signaling Axis in Drug Discovery for Cancer Therapy. Cancers 2021; 13(8): 1898 doi: 10.3390/cancers13081898
|
| 8 |
Yuchan Wang, Shuhui Zhou, Xiaojing Yang, Hui Shi, Mei Li, Qun Xue, Xianting Huang, Xinxiu Wang, Huijie Wang, Jianguo Zhang. Low expression of cyclic amp response element modulator-1 can increase the migration and invasion of esophageal squamous cell carcinoma. Tumor Biology 2013; 34(6): 3649 doi: 10.1007/s13277-013-0946-1
|
| 9 |
Shailaja Mahajan-Thakur, Sandra Bien-Möller, Sascha Marx, Henry Schroeder, Bernhard H. Rauch. Sphingosine 1-Phosphate (S1P) Signaling in Glioblastoma Multiforme—A Systematic Review. International Journal of Molecular Sciences 2017; 18(11): 2448 doi: 10.3390/ijms18112448
|
| 10 |
Guillaume Andrieu, Adeline Ledoux, Sophie Branka, Magalie Bocquet, Julia Gilhodes, Thierry Walzer, Kousuke Kasahara, Masaki Inagaki, Roger A. Sabbadini, Olivier Cuvillier, Anastassia Hatzoglou.
Sphingosine 1-phosphate signaling through its receptor S1P
5
promotes chromosome segregation and mitotic progression
. Science Signaling 2017; 10(472) doi: 10.1126/scisignal.aah4007
|
| 11 |
Zhen Zeng, Chunxiang Ma, Kexin Chen, Mingshan Jiang, Reshma Vasu, Rui Liu, Yinglan Zhao, Hu Zhang. Roles of G Protein-Coupled Receptors (GPCRs) in Gastrointestinal Cancers: Focus on Sphingosine 1-Shosphate Receptors, Angiotensin II Receptors, and Estrogen-Related GPCRs. Cells 2021; 10(11): 2988 doi: 10.3390/cells10112988
|
| 12 |
Clayton S. Lewis, Christina Voelkel-Johnson, Charles D. Smith. Sphingolipids in Cancer. Advances in Cancer Research 2018; 140: 295 doi: 10.1016/bs.acr.2018.04.015
|
| 13 |
Lian Fang, Jiangtao Hou, Yihui Cao, Jia-Jie Shan, Jie Zhao. Spinster homolog 2 in cancers, its functions and mechanisms. Cellular Signalling 2021; 77: 109821 doi: 10.1016/j.cellsig.2020.109821
|
| 14 |
Fabian Cordts, Stuart Pitson, Christoph Tabeling, Ian Gibbins, David F. Moffat, Hubertus Jersmann, Sandra Hodge, Rainer V. Haberberger. Expression profile of the sphingosine kinase signalling system in the lung of patients with chronic obstructive pulmonary disease. Life Sciences 2011; 89(21-22): 806 doi: 10.1016/j.lfs.2011.08.018
|
| 15 |
Yan Chen, Jing Dai, Peng Chen, Quan Dai, Ya Chen, Yuying Li, Man Lu, Shugang Qin, Qiuju Wang. Long non-coding RNAs-sphingolipid metabolism nexus: Potential targets for cancer treatment. Pharmacological Research 2024; 210: 107539 doi: 10.1016/j.phrs.2024.107539
|
| 16 |
Suriyan Ponnusamy, Marisa Meyers-Needham, Can E Senkal, Sahar A Saddoughi, David Sentelle, Shanmugam Panneer Selvam, Arelis Salas, Besim Ogretmen. Sphingolipids and Cancer: Ceramide and Sphingosine-1-Phosphate in the Regulation of Cell Death and Drug Resistance. Future Oncology 2010; 6(10): 1603 doi: 10.2217/fon.10.116
|
| 17 |
Chunyi Wang, Jinghe Mao, Samantha Redfield, Yinyuan Mo, Janice M. Lage, Xinchun Zhou. Systemic distribution, subcellular localization and differential expression of sphingosine-1-phosphate receptors in benign and malignant human tissues. Experimental and Molecular Pathology 2014; 97(2): 259 doi: 10.1016/j.yexmp.2014.07.013
|
| 18 |
Nidhi V. Dwivedi, Souvik Datta, Karim El‐Kersh, Ruxana T. Sadikot, Apar K. Ganti, Surinder K. Batra, Maneesh Jain. GPCRs and fibroblast heterogeneity in fibroblast‐associated diseases. The FASEB Journal 2023; 37(8) doi: 10.1096/fj.202301091
|
| 19 |
Jessie W. Yester, Etsegenet Tizazu, Kuzhuvelil B. Harikumar, Tomasz Kordula. Extracellular and intracellular sphingosine-1-phosphate in cancer. Cancer and Metastasis Reviews 2011; 30(3-4): 577 doi: 10.1007/s10555-011-9305-0
|
| 20 |
Jinzhong Liu, Zhenfeng Li, Jing Cui, Gang Xu, Guanglin Cui. Cellular changes in the tumor microenvironment of human esophageal squamous cell carcinomas. Tumor Biology 2012; 33(2): 495 doi: 10.1007/s13277-011-0281-3
|
| 21 |
Xue, MS Jinru, Yang, MS Yu, Jiang, MD Bo, Qian, MD Linxue, Shi, PhD Xian-Quan. Identification of Key Genes Between Lung Adenocarcinoma and Lung Squamous Cell Carcinoma by Bioinformatics Analysis. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY 2020; 4(4): 335 doi: 10.37015/AUDT.2020.200011
|
| 22 |
Catherine Olesch, Christian Ringel, Bernhard Brüne, Andreas Weigert. Beyond Immune Cell Migration: The Emerging Role of the Sphingosine-1-phosphate Receptor S1PR4 as a Modulator of Innate Immune Cell Activation. Mediators of Inflammation 2017; 2017: 1 doi: 10.1155/2017/6059203
|
| 23 |
Paulette Tamashiro, Hideki Furuya, Yoshiko Shimizu, Kayoko Iino, Toshihiko Kawamori. The Impact of Sphingosine Kinase-1 in Head and Neck Cancer. Biomolecules 2013; 3(3): 481 doi: 10.3390/biom3030481
|
| 24 |
Kati Kemppainen, Nina Wentus, Taru Lassila, Asta Laiho, Kid Törnquist. Sphingosylphosphorylcholine regulates the Hippo signaling pathway in a dual manner. Cellular Signalling 2016; 28(12): 1894 doi: 10.1016/j.cellsig.2016.09.004
|
| 25 |
Olga Sukocheva. Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming. International Journal of Molecular Sciences 2018; 19(2): 420 doi: 10.3390/ijms19020420
|
| 26 |
Ilari Pulli, Muhammad Yasir Asghar, Kati Kemppainen, Kid Törnquist. Sphingolipid-mediated calcium signaling and its pathological effects. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2018; 1865(11): 1668 doi: 10.1016/j.bbamcr.2018.04.012
|
| 27 |
Gabriela Schneider. Tumor Microenvironment. Advances in Experimental Medicine and Biology 2020; 1223: 129 doi: 10.1007/978-3-030-35582-1_7
|
| 28 |
Olga A. Sukocheva, Hideki Furuya, Mei Li Ng, Markus Friedemann, Mario Menschikowski, Vadim V. Tarasov, Vladimir N. Chubarev, Sergey G. Klochkov, Margarita E. Neganova, Arduino A. Mangoni, Gjumrakch Aliev, Anupam Bishayee. Sphingosine kinase and sphingosine-1-phosphate receptor signaling pathway in inflammatory gastrointestinal disease and cancers: A novel therapeutic target. Pharmacology & Therapeutics 2020; 207: 107464 doi: 10.1016/j.pharmthera.2019.107464
|
| 29 |
Sathya Narayanan Patmanathan, Wei Wang, Lee Fah Yap, Deron R. Herr, Ian C. Paterson. Mechanisms of sphingosine 1-phosphate receptor signalling in cancer. Cellular Signalling 2017; 34: 66 doi: 10.1016/j.cellsig.2017.03.002
|
| 30 |
Mathieu Fortier, Nicolas Figeac, Robert B. White, Paul Knopp, Peter S. Zammit. Sphingosine-1-phosphate receptor 3 influences cell cycle progression in muscle satellite cells. Developmental Biology 2013; 382(2): 504 doi: 10.1016/j.ydbio.2013.07.006
|
| 31 |
Peng Wang, Yonghui Yuan, Wenda Lin, Hongshan Zhong, Ke Xu, Xun Qi. Roles of sphingosine-1-phosphate signaling in cancer. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-1014-8
|
| 32 |
Eileen M. McGowan, Yiguang Lin, Size Chen. Targeting Chronic Inflammation of the Digestive System in Cancer Prevention: Modulators of the Bioactive Sphingolipid Sphingosine-1-Phosphate Pathway. Cancers 2022; 14(3): 535 doi: 10.3390/cancers14030535
|
| 33 |
Catherine Olesch, Bernhard Brüne, Andreas Weigert. Keep a Little Fire Burning—The Delicate Balance of Targeting Sphingosine-1-Phosphate in Cancer Immunity. International Journal of Molecular Sciences 2022; 23(3): 1289 doi: 10.3390/ijms23031289
|
| 34 |
Yuna Kim, Sungho Ghil. Negative regulation of cannabinoid receptor 2‑induced tumorigenic effect by sphingosine‑1‑phosphate receptor 5 activation. Oncology Reports 2025; 53(3) doi: 10.3892/or.2025.8874
|